Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04459455 · ClinicalTrials.gov registry record · NA

Project H-COVID: Evaluating Hyper-Brief, Online Materials During the COVID-19 Pandemic

A NA study of Anxiety, sponsored by Stony Brook University.

Completed
Registry status
NA
Development phase
500
Enrollment target
1
Study location

NCT04459455 is a NA study of Anxiety that has completed, run by Stony Brook University. The registered enrollment target is 500 participants, above the 439-participant average among 364 other Anxiety trials with a reported enrollment target (14% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04459455, a NA study of Anxiety, has completed, sponsored by Stony Brook University.

COMPLETED
Registry status
NA
Development phase
500 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to test whether an online, self-administered SSI designed to strengthen perceived control over anxiety in the context of the COVID-19 pandemic (Contain COVID Anxiety) increases perceived control over anxiety more than a placebo, hand-washing-plan SSI (Remain COVID Free) in a weighted-probability sample of the United States (N = 500).

Conditions Studied

Interventions

  • BEHAVIORAL Contain COVID Anxiety SSI
  • BEHAVIORAL Remain COVID Free SSI

Study Locations (1)

New York

  • Stony Brook University - Stony Brook

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2020-08-19
Est. Completion 2020-10-15
Phase NA

Sponsor

Stony Brook University

127 total trials

What the Registry Record Tells You About NCT04459455

The ClinicalTrials.gov registry entry for NCT04459455 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 439-participant average among 364 other Anxiety trials with a reported enrollment target (14% higher). The listed sponsor is Stony Brook University, which has 127 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Anxiety appearing as the primary indexed condition, and to 2 interventions - of which Contain COVID Anxiety SSI is the first listed.

NCT04459455 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04459455 about?

NCT04459455 is a clinical study titled "Project H-COVID: Evaluating Hyper-Brief, Online Materials During the COVID-19 Pandemic". The goal of this study is to test whether an online, self-administered SSI designed to strengthen perceived control over anxiety in the context of the COVID-19 pandemic (Contain COVID Anxiety) increases perceived control over anxiety more than a placebo, hand-washing-plan SSI (Remain COVID Free) in ...

What is the current status of trial NCT04459455?

This trial is currently completed. It is a NA study. The enrollment target is 500 participants. The study started on 2020-08-19. Estimated completion is 2020-10-15.

What conditions does trial NCT04459455 study?

This clinical trial studies the following conditions: Anxiety.

What interventions are being tested in trial NCT04459455?

The interventions under investigation include: Contain COVID Anxiety SSI (BEHAVIORAL), Remain COVID Free SSI (BEHAVIORAL).

Who is sponsoring clinical trial NCT04459455?

This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04459455 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.